300298 三诺生物
已收盘 11-19 15:00:00
资讯
新帖
简况
11月18日三诺生物跌6.72%,睿远成长价值混合A基金重仓该股
证券之星 · 11-18 16:20
11月18日三诺生物跌6.72%,睿远成长价值混合A基金重仓该股
11月12日三诺生物现1笔大宗交易 机构净买入372.49万元
证券之星 · 11-12
11月12日三诺生物现1笔大宗交易 机构净买入372.49万元
三诺生物最新公告:取得两项医疗器械注册证
证券之星 · 11-08
三诺生物最新公告:取得两项医疗器械注册证
三诺生物(300298.SZ)取得两项医疗器械注册证
智通财经 · 11-08
三诺生物(300298.SZ)取得两项医疗器械注册证
华福证券:给予三诺生物买入评级
证券之星 · 11-08
华福证券:给予三诺生物买入评级
三诺生物(300298)股东李少波质押772万股,占总股本1.37%
证券之星 · 11-01
三诺生物(300298)股东李少波质押772万股,占总股本1.37%
三诺生物(300298)10月31日主力资金净卖出382.40万元
证券之星 · 11-01
三诺生物(300298)10月31日主力资金净卖出382.40万元
华源证券:给予三诺生物买入评级
证券之星 · 10-30
华源证券:给予三诺生物买入评级
华安证券:给予三诺生物买入评级
证券之星 · 10-29
华安证券:给予三诺生物买入评级
睿远旗下4只基金三季报披露!傅鹏博、朱璘:留出头寸等待增持机会
智通财经网 · 10-25
睿远旗下4只基金三季报披露!傅鹏博、朱璘:留出头寸等待增持机会
圣湘生物、三诺生物等5家医疗器械公司发布三季报,仅1家实现净利润增长
中国制药网 · 10-24
圣湘生物、三诺生物等5家医疗器械公司发布三季报,仅1家实现净利润增长
三诺生物最新公告:前三季度净利润2.55亿元 同比下降19.71%
证券之星 · 10-23
三诺生物最新公告:前三季度净利润2.55亿元 同比下降19.71%
三诺生物(300298.SZ)发布前三季度业绩,净利润2.55亿元,同比下降19.71%
智通财经 · 10-23
三诺生物(300298.SZ)发布前三季度业绩,净利润2.55亿元,同比下降19.71%
三诺生物:10月10日接受机构调研,投资者参与
证券之星 · 10-10
三诺生物:10月10日接受机构调研,投资者参与
10月9日三诺生物跌9.30%,睿远成长价值混合A基金重仓该股
证券之星 · 10-09
10月9日三诺生物跌9.30%,睿远成长价值混合A基金重仓该股
9月27日三诺生物涨7.49%,睿远成长价值混合A基金重仓该股
证券之星 · 09-27
9月27日三诺生物涨7.49%,睿远成长价值混合A基金重仓该股
9月26日三诺生物涨5.27%,睿远成长价值混合A基金重仓该股
证券之星 · 09-26
9月26日三诺生物涨5.27%,睿远成长价值混合A基金重仓该股
三诺生物涨5.27%,华安证券四周前给出“买入”评级
证券之星 · 09-26
三诺生物涨5.27%,华安证券四周前给出“买入”评级
三诺生物最新公告:预计将获得政府补助资金1676.59万元
证券之星 · 09-25
三诺生物最新公告:预计将获得政府补助资金1676.59万元
三诺生物新注册《便携式全自动多功能检测仪软件V1.0》项目的软件著作权
证券之星 · 09-13
三诺生物新注册《便携式全自动多功能检测仪软件V1.0》项目的软件著作权
加载更多
公司概况
公司名称:
三诺生物传感股份有限公司
所属行业:
专用设备制造业
上市日期:
2012-03-19
主营业务:
三诺生物传感股份有限公司致力于血糖监测系统的生产和销售。其主要产品有血糖监测系统、血脂检测系统、糖化血红蛋白检测系统。公司生产的血糖监测及慢病检测系统以其“准确、简单、可负担”的特点获得广大消费者和医护人员的认可,在糖尿病患者人群中拥有较高的品牌影响力,公司“三诺”商标被评为“中国驰名商标”,是国内唯一一家血糖仪生产企业获此认定,先后获得湖南省最具民生影响力品牌企业、湖南省上市公司卓越品牌奖、中国店员推荐率最高品牌、湖南省名优品牌推荐榜上榜品牌、湖南省质量服务百强品牌、湖南省名优推介榜上榜品牌等称号。
发行价格:
29.00
{"stockData":{"symbol":"300298","market":"SZ","secType":"STK","nameCN":"三诺生物","latestPrice":25,"timestamp":1731999822000,"preClose":24,"halted":0,"volume":5153100,"delay":0,"floatShares":455000000,"shares":564000000,"eps":0.393,"marketStatus":"已收盘","marketStatusCode":5,"change":1,"latestTime":"11-19 15:00:00","open":24.22,"high":25.08,"low":24.08,"amount":127000000,"amplitude":0.0417,"askPrice":25.01,"askSize":10,"bidPrice":25,"bidSize":50,"shortable":0,"etf":0,"ttmEps":0.393,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732066200000},"adr":0,"adjPreClose":24,"symbolType":"stock","openAndCloseTimeList":[[1731979800000,1731987000000],[1731992400000,1731999600000]],"highLimit":26.4,"lowLimit":21.6,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":564265375,"pbRate":4.44,"roa":"--","roe":"7.95%","epsLYR":0.5107,"committee":0.087794,"marketValue":14107000000,"floatMarketCap":11384000000,"peRate":63.61323,"changeRate":0.0417,"turnoverRate":0.0113,"status":0},"requestUrl":"/m/hq/s/300298","defaultTab":"news","newsList":[{"id":"2484610904","title":"11月18日三诺生物跌6.72%,睿远成长价值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484610904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484610904?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:20","pubTimestamp":1731918038,"startTime":"0","endTime":"0","summary":"证券之星消息,11月18日三诺生物跌6.72%,收盘报24.0元,换手率1.76%,成交量8.01万手,成交额1.98亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共22家,其中持有数量最多的公募基金为睿远成长价值混合A。睿远成长价值混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800019930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0114","BK0102","BK0251"],"gpt_icon":0},{"id":"2482277367","title":"11月12日三诺生物现1笔大宗交易 机构净买入372.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482277367","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482277367?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:47","pubTimestamp":1731401220,"startTime":"0","endTime":"0","summary":"证券之星消息,11月12日三诺生物发生大宗交易,交易数据如下:大宗交易成交价格27.47元,成交13.56万股,成交金额372.49万元,买方营业部为机构专用,卖方营业部为中国中金财富证券有限公司深圳分公司。近三个月该股共发生1笔大宗交易,合计成交1356.0手。截至2024年11月12日收盘,三诺生物报收于27.47元,上涨1.25%,换手率1.74%,成交量7.93万手,成交额2.2亿元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200026810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0102","BK0114","BK0251"],"gpt_icon":0},{"id":"2481312843","title":"三诺生物最新公告:取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2481312843","media":"证券之星","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481312843?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:21","pubTimestamp":1731057680,"startTime":"0","endTime":"0","summary":"三诺生物公告,公司近日收到湖南省药品监督管理局颁发的两项《医疗器械注册证》,产品分别为25-羟基维生素D测定试剂盒(荧光免疫层析法)和全量程C反应蛋白/血清淀粉样蛋白A测定试剂盒(荧光免疫层析法),注册证有效期均为2024年10月30日至2029年10月29日。这两项注册证的取得丰富了公司检测产品的品类,有助于满足市场多元化的检测需求,增强了公司医疗器械产品的综合竞争力。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800028798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300298","BK1100","BK1583","159883","BK0251","BK1574","BK1222","09997","BK0114","09996"],"gpt_icon":0},{"id":"2481662128","title":"三诺生物(300298.SZ)取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2481662128","media":"智通财经","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481662128?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:20","pubTimestamp":1731057644,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三诺生物(300298.SZ)公告,公司近日收到湖南省药品监督管理局颁发的两项《医疗器械注册证》,产品名称为:25-羟基维生素D测定试剂盒(荧光免疫层析法)、全量程C反应蛋白/血清淀粉样蛋白A测定试剂盒(荧光免疫层析法)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","159883","300298","09997","BK0102","BK1222","BK0251","BK1574","BK1100","09996","BK0114"],"gpt_icon":0},{"id":"2481112671","title":"华福证券:给予三诺生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481112671","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481112671?lang=zh_cn&edition=full","pubTime":"2024-11-08 14:40","pubTimestamp":1731048031,"startTime":"0","endTime":"0","summary":"华福证券有限责任公司陈铁林,王艳,黄冠群近期对三诺生物进行研究并发布了研究报告《利润端受费用增加影响,CGM出海有序推进》,本报告对三诺生物给出买入评级,当前股价为26.97元。 母公司传统业务收入增速有所放缓,核心受渠道业务调整及同期促销策略影响。最新盈利预测明细如下:该股最近90天内共有17家机构给出评级,买入评级14家,增持评级3家;过去90天内机构目标均价为31.77。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800018932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","161027"],"gpt_icon":0},{"id":"2480688540","title":"三诺生物(300298)股东李少波质押772万股,占总股本1.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480688540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480688540?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:21","pubTimestamp":1730467297,"startTime":"0","endTime":"0","summary":"证券之星消息,三诺生物11月1日公开信息显示,股东李少波向中国中金财富证券股份有限公司合计质押772.0万股,占总股本1.37%。质押详情见下表:截止本公告日,股东李少波已累计质押股份8327.0万股,占其持股总数的58.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100046794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0102","BK0114","BK0251"],"gpt_icon":0},{"id":"2480161240","title":"三诺生物(300298)10月31日主力资金净卖出382.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480161240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480161240?lang=zh_cn&edition=full","pubTime":"2024-11-01 09:21","pubTimestamp":1730424095,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月31日收盘,三诺生物报收于26.02元,下跌2.55%,换手率1.39%,成交量6.34万手,成交额1.66亿元。近5日资金流向一览见下表:三诺生物融资融券信息显示,融资方面,当日融资买入1040.16万元,融资偿还657.12万元,融资净买入383.04万元,连续3日净买入累计1036.64万元。三诺生物主营业务:血糖监测系统、糖化血红蛋白检测系统、血脂检测系统、血压计等生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100010692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","300298","BK0251","BK0102"],"gpt_icon":0},{"id":"2479110214","title":"华源证券:给予三诺生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479110214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479110214?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:57","pubTimestamp":1730260642,"startTime":"0","endTime":"0","summary":"华源证券股份有限公司刘闯近期对三诺生物进行研究并发布了研究报告《Q3销售费用率提升+加大研发费用投入拖累利润》,本报告对三诺生物给出买入评级,当前股价为26.67元。公司为血糖监测行业龙头,新产品CGM正在快速增长中,海外发力在即,天花板持续打开,维持公司“买入”评级。最新盈利预测明细如下:该股最近90天内共有16家机构给出评级,买入评级13家,增持评级3家;过去90天内机构目标均价为31.77。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000019725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","161027"],"gpt_icon":0},{"id":"2479460604","title":"华安证券:给予三诺生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479460604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479460604?lang=zh_cn&edition=full","pubTime":"2024-10-29 07:50","pubTimestamp":1730159423,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,李婵近期对三诺生物进行研究并发布了研究报告《2024Q3费用投入加大影响利润,CGM出海在即》,本报告对三诺生物给出买入评级,当前股价为27.84元。我们预计2025年公司CGM海外市场将贡献一定的收入,2026年将进入大规模放量阶段。最新盈利预测明细如下:该股最近90天内共有16家机构给出评级,买入评级13家,增持评级3家;过去90天内机构目标均价为31.77。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900007541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","300298"],"gpt_icon":0},{"id":"2478677000","title":"睿远旗下4只基金三季报披露!傅鹏博、朱璘:留出头寸等待增持机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2478677000","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478677000?lang=zh_cn&edition=full","pubTime":"2024-10-25 16:07","pubTimestamp":1729843650,"startTime":"0","endTime":"0","summary":"10月25日,睿远基金旗下4只公募产品披露了2024年三季报。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20241025/20241025160747_57341.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241025/20241025160747_57341.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1199711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0228659784.USD","LU0359201885.HKD","LU1820825898.SGD","300751","002444","BK0044","02601","LU2328871848.SGD","03143","LU1497734951.SGD","LU0821914370.USD","688210","IE00B031HY20.USD","601318","600309","EVS.SI","01398","LU2580892789.USD","300298","BK0256","LU0043850808.USD","IE00B19Z5X02.USD","600233","600585","002475","80883","IE00B97KM107.HKD","00700","80700","BK0175","LU0269904917.USD","600256","06078","00941","IE00BQJZWZ67.USD","02328","IE00BZ08YS42.EUR","LU0543330483.HKD","LU0651946864.USD","600019","LU1023057109.AUD","LU0054450605.USD","BK1591","BK0032","IE0005HP3H50.USD","LU0067412154.USD","LU1051768304.USD","300750","300037","601827"],"gpt_icon":1},{"id":"2477422573","title":"圣湘生物、三诺生物等5家医疗器械公司发布三季报,仅1家实现净利润增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2477422573","media":"中国制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477422573?lang=zh_cn&edition=full","pubTime":"2024-10-24 14:34","pubTimestamp":1729751657,"startTime":"0","endTime":"0","summary":"上市 医疗器械 公司三季报正陆续披露。10月24日,有5家发布成绩单,分别是 圣湘生物 、 三诺生物 、 港通医疗 、 凯利泰 和 福瑞股份 ,从净利润变动情况来看,仅1家实现净利润增长,即福瑞股份。另外4家医疗器械公司前三季度均有所承压。信达证券 表示,10月份医疗上市公司将陆续披露2024年三季报,短期或可关注业绩有望超预期的个股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024143809ab6f6353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024143809ab6f6353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688289","159883","300298"],"gpt_icon":0},{"id":"2477534655","title":"三诺生物最新公告:前三季度净利润2.55亿元 同比下降19.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477534655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477534655?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:49","pubTimestamp":1729694976,"startTime":"0","endTime":"0","summary":"三诺生物发布2024年第三季度报告,前三季度实现营业收入31.82亿元,同比增长4.83%;归属于上市公司股东的净利润2.55亿元,同比下降19.71%。第三季度实现营业收入10.49亿元,同比增长2.05%;归属于上市公司股东的净利润5785.67万元,同比下降59.44%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300038277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298"],"gpt_icon":0},{"id":"2477658111","title":"三诺生物(300298.SZ)发布前三季度业绩,净利润2.55亿元,同比下降19.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477658111","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477658111?lang=zh_cn&edition=full","pubTime":"2024-10-23 20:31","pubTimestamp":1729686670,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三诺生物(300298.SZ)披露2024年第三季度报告,公司前三季度实现营收31.82亿元,同比增长4.83%;归母净利润2.55亿元,同比下降19.71%;扣非净利润2.32亿元,同比下降31.73%;基本每股收益0.4605元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300298"],"gpt_icon":0},{"id":"2474167417","title":"三诺生物:10月10日接受机构调研,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2474167417","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474167417?lang=zh_cn&edition=full","pubTime":"2024-10-10 19:11","pubTimestamp":1728558706,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年10月10日三诺生物发布公告称公司于2024年10月10日接受机构调研。三诺生物2024年中报显示,公司主营收入21.33亿元,同比上升6.26%;归母净利润1.97亿元,同比上升12.61%;扣非净利润1.78亿元,同比下降10.38%;其中2024年第二季度,公司单季度主营收入11.19亿元,同比下降0.53%;单季度归母净利润1.17亿元,同比上升0.78%;单季度扣非净利润1.01亿元,同比下降25.42%;负债率39.77%,投资收益70.67万元,财务费用485.43万元,毛利率55.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101000033244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0251","BK0102","BK0114"],"gpt_icon":0},{"id":"2474121155","title":"10月9日三诺生物跌9.30%,睿远成长价值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474121155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474121155?lang=zh_cn&edition=full","pubTime":"2024-10-09 17:32","pubTimestamp":1728466336,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日三诺生物跌9.30%,收盘报29.76元,换手率2.25%,成交量10.22万手,成交额3.16亿元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共24家,其中持有数量最多的公募基金为睿远成长价值混合A。睿远成长价值混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900031581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","300298","BK0251","BK0102"],"gpt_icon":0},{"id":"2470177106","title":"9月27日三诺生物涨7.49%,睿远成长价值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470177106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470177106?lang=zh_cn&edition=full","pubTime":"2024-09-27 17:05","pubTimestamp":1727427926,"startTime":"0","endTime":"0","summary":"证券之星消息,9月27日三诺生物涨7.49%创60日新高,收盘报27.27元,换手率1.2%,成交量5.45万手,成交额1.45亿元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共24家,其中持有数量最多的公募基金为睿远成长价值混合A。睿远成长价值混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700025988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0251","BK0114","BK0102"],"gpt_icon":0},{"id":"2470088204","title":"9月26日三诺生物涨5.27%,睿远成长价值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470088204","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470088204?lang=zh_cn&edition=full","pubTime":"2024-09-26 16:51","pubTimestamp":1727340695,"startTime":"0","endTime":"0","summary":"证券之星消息,9月26日三诺生物涨5.27%,收盘报25.37元,换手率0.85%,成交量3.88万手,成交额9540.42万元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共24家,其中持有数量最多的公募基金为睿远成长价值混合A。睿远成长价值混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092600024109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0102","300298","BK0251"],"gpt_icon":0},{"id":"2470202893","title":"三诺生物涨5.27%,华安证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2470202893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470202893?lang=zh_cn&edition=full","pubTime":"2024-09-26 16:51","pubTimestamp":1727340689,"startTime":"0","endTime":"0","summary":"今日三诺生物涨5.27%,收盘报25.37元。2024年8月29日,华安证券研究员谭国超,李婵发布了对三诺生物的研报《2024H1血糖业务毛利率持续提升,盈利能力增强》,该研报对三诺生物给出“买入”评级。此外,国金证券研究员袁维,何冠洲,东吴证券研究员朱国广近期也对该股发布了研报,同样给出“买入”评级。三诺生物个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092600024103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","300298"],"gpt_icon":0},{"id":"2470523096","title":"三诺生物最新公告:预计将获得政府补助资金1676.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470523096","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470523096?lang=zh_cn&edition=full","pubTime":"2024-09-25 19:00","pubTimestamp":1727262011,"startTime":"0","endTime":"0","summary":"三诺生物公告,公司于2024年9月24日收到国家税务总局湖南湘江新区税务局关于软件产品增值税退税的通知,预计将获得政府补助资金人民币1676.59万元,占公司最近一期经审计归属于上市公司股东的净利润的5.90%。上述政府补助将计入“其他收益”,预计将对公司2024年度税前利润总额的影响金额为1676.59万元。但需注意,上述政府补助资金尚未实际到账,实际收到政府补助的时间存在不确定性。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092500029152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0102","BK0114","300298"],"gpt_icon":0},{"id":"2467200789","title":"三诺生物新注册《便携式全自动多功能检测仪软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2467200789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467200789?lang=zh_cn&edition=full","pubTime":"2024-09-13 01:24","pubTimestamp":1726161849,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三诺生物(300298)新注册了《便携式全自动多功能检测仪软件V1.0》项目的软件著作权。今年以来三诺生物新注册软件著作权10个,较去年同期减少了16.67%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了1.71亿元,同比增6.14%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091300001675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0251","BK0102","BK0114"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2012-03-19","address":"湖南省长沙市岳麓区高新技术产业开发区谷苑路265号","stockEarnings":[{"period":"1week","weight":-0.0899},{"period":"1month","weight":-0.1328},{"period":"3month","weight":0.0711},{"period":"6month","weight":-0.018},{"period":"1year","weight":-0.1149},{"period":"ytd","weight":-0.1714}],"companyName":"三诺生物传感股份有限公司","boardCode":"AI0035","perCapita":"49376股","boardName":"专用设备制造业","registeredCapital":"56426万元","compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":0.0259},{"period":"3month","weight":0.1713},{"period":"6month","weight":0.0737},{"period":"1year","weight":0.0905},{"period":"ytd","weight":0.1247}],"survey":" 三诺生物传感股份有限公司致力于血糖监测系统的生产和销售。其主要产品有血糖监测系统、血脂检测系统、糖化血红蛋白检测系统。公司生产的血糖监测及慢病检测系统以其“准确、简单、可负担”的特点获得广大消费者和医护人员的认可,在糖尿病患者人群中拥有较高的品牌影响力,公司“三诺”商标被评为“中国驰名商标”,是国内唯一一家血糖仪生产企业获此认定,先后获得湖南省最具民生影响力品牌企业、湖南省上市公司卓越品牌奖、中国店员推荐率最高品牌、湖南省名优品牌推荐榜上榜品牌、湖南省质量服务百强品牌、湖南省名优推介榜上榜品牌等称号。","serverTime":1732048536724,"listedPrice":29,"stockholders":"9222人(较上一季度增加0.63%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三诺生物,300298,三诺生物股票,三诺生物股票老虎,三诺生物股票老虎国际,三诺生物行情,三诺生物股票行情,三诺生物股价,三诺生物股市,三诺生物股票价格,三诺生物股票交易,三诺生物股票购买,三诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}